[1] |
Thewes B,Meiser B,Taylor A,et al.Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer.J Clin Oncol,2005,23:5155-5165.
|
[2] |
Duffy CM,Allen SM,Clark MA.Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.J Clin Oncol,2005,23:766-773.
|
[3] |
Partridge AH,Gelber S,Peppercorn J,et al.Web-based survey of fertility issues in young women with breast cancer.J Clin Oncol,2004,22:4174-4183.
|
[4] |
Bines J,Oleske D,Cobleigh M.Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.J Clin Oncol,1996,14:1718-1729.
|
[5] |
Minton SE,Munster PN.Chemotherapy-induced amenorrhoea and fertility in women undergoing adjuvant treatment for breast cancer.Cancer Control,2002,9:466-472.
|
[6] |
Hortobagyi GN,Buzdar AU,Marcus CE,et al.Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at MD Anderson Hospital and Tumor Institute.NCI Monogr,1986,1:105-109.
|
[7] |
Goodwin PJ,Ennis M,Pritchard KI,et al.Risk of menopause during the first year after breast cancer diagnosis.J Clin Oncol,1999,17:2365-2370.
|
[8] |
Parulekar WR,Day AG,Ottaway JA,et al.Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer:analysis of a National Cancer Institute of Canada Clinical Trials Group Study-NCIC CTG MA 5.J Clin Oncol,2005,23:6002-6008.
|
[9] |
Petrek JA,Naughton MJ,Case LD,et al.Incidence,time course,and determinants of menstrual bleeding after breast cancer treatment:a prospective study.J Clin Oncol,2006,24:1045-1051.
|
[10] |
Martin M,Pienkowski T,Mackey J,et al.Adjuvant docetaxel for node-positive breast cancer.N Engl J Med,2005,352:2302-2313.
|
[11] |
Davis AL,Klitus M,Mintzer DM.Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment:the effect of the addition of taxanes.Clin Breast Cancer,2005,6:421-424.
|
[12] |
Kramer R,Tham YL,Sexton K,et al.Chemotherapy-induced amenorrhea is increased in patients treated with adjuvant doxorubicin and cyclophosphamide(AC)followed by a taxane(T):ASCO annual meeting proceedings.J Clin Oncol,2005,23:651.
|
[13] |
Fornier MN,Modi S,Panageas KS,et al.Incidence of chemotherapy-induced,long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.Cancer,2005,104:1575-1579.
|
[14] |
Mueller BA,Simon MS,Deapen D,et al.Childbearing and survival after breast carcinoma in young women.Cancer,2003,98:1131-1140.
|
[15] |
Kroman N,Jensen MB,Wohlfahrt J,et al.Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative Group.Acta Oncol,2008,47:545-549.
|
[16] |
Ives A,Saunders C,Bulsara M,et al.Pregnancy after breast cancer:population based study.BMJ,2007,334:194-196.
|
[17] |
Sankila R,Heinavaara S,Hakulinen T.Survival of breast cancer patients after subsequent term pregnancy:“healthy mother effect”.Am J Obstet Gynecol,1994,170:818-823.
|
[18] |
von Schoultz E,Johansson H,Wilking N,et al.Influence of prior and subsequent pregnancy on breast cancer prognosis.J Clin Oncol,1995,13:430-434.
|
[19] |
Velentgas P,Daling JR,Malone KE,et al.Pregnancy after breast carcinoma:outcomes and influence on mortality.Cancer,1999,85:2424-2432.
|
[20] |
Gelber S,Coates AS,Goldhirsch A,et al.Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.J Clin Onco,2001,19:1671-1675.
|
[21] |
Blakely LJ,Buzdar AU,Lozada JA,et al.Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.Cancer,2004,100:465-469.
|
[22] |
Hawkins MM.Pregnancy outcome and offspring after childhood cancer.BMJ,1994,309:1034.
|
[23] |
Lambe M,Hsieh C,Trichopoulos D,et al.Transient increase in the risk of breast cancer after giving birth.N Engl J Med,1994,331:5-9.
|
[24] |
Hsieh C,Pavia M,Lambe M,et al.Dual effect of parity on breast cancer risk.Eur J Cancer,1994,30A:969-973.
|
[25] |
Leon DA,Carpenter LM,Broeders MJ,et al.Breast cancer in Swedish women before age 50:evidence of a dual effect of completed pregnancy.Cancer Causes Control,1995,6:283-291.
|
[26] |
Russo J,Moral R,Balogh GA,et al.The protective role of pregnancy in breast cancer.Breast Cancer Res,2005,7:131-142.
|
[27] |
Russo J,Russo IH.The etiopathogenesis of breast cancer prevention.Cancer Lett,1995,90:81-89.
|
[28] |
D'Cruz CM,Moody SE,Master SR,et al.Persistent parity-induced changes in growth factors,TGF-beta3,and differentiation in the rodent mammary gland.Mol Endocrinol,2002,16:2034-2051.
|
[29] |
Booth D,Haley JD,Bruskin AM,et al.Transforming growth factor-B3 protects murine small intestinal crypt stem cells and animal survival after irradiation,possibly by reducing stem-cell cycling.Int J Cancer,2000,86:53-59.
|
[30] |
Dao MA,Hwa J,Nolta JA.Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+)progenitors.Blood,2002,99:499-506.
|
[31] |
Sakariassen PO,Immervoll H,Chekenya M.Cancer stem cells as mediators of treatment resistance in brain tumors:status and controversies.Neoplasia,2007,9:882-892.
|
[32] |
Tang C,Chua CL,Ang BT.Insights into the cancer stem cell model of glioma tumorigenesis.Ann Acad Med Singapore,2007,36:352-357.
|
[33] |
Yuri T,Tsukamoto R,Miki K,et al.Biphasic effects of zeranol on the growth of estrogen receptor-positive human breast carcinoma cells.Oncol Rep,2006,16:1307-1312.
|